Literature DB >> 8905882

Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia.

K Cherukupalli1, J E Larson, A Rotschild, W M Thurlbeck.   

Abstract

We correlated clinical, biochemical, and morphologic findings in the lungs of 48 infants dying of either bronchopulmonary dysplasia (BPD) or hyaline membrane disease (HMD) to obtain a better idea of the disease process. The infants ranged from 24 weeks of gestation to 1 1/2 postnatal years. The lungs of BPD and HMD infants had higher contents of DNA, alkalisoluble protein, hydroxyproline, and desmosine, as well as increased concentrations of DNA, hydroxyproline, and desmosine when compared with the lungs of 72 control infants. BPD was classified histologically into 4 groups: Group I was a phase of acute lung injury, Group II the proliferative phase; Group III the phase of early repair, and Group IV the phase of late repair. We saw a significant increase in hydroxyproline concentration in Groups II and III. The ratio of type I/III collagen decreased in BPD Groups II to IV. Desmosine was significantly higher only in Group III than in controls. When the pathological classification was related to biochemical and clinical features of BPD, the classification showed dependence on the number of days the infant survived postnatally and not on the gestational age of the infant. The number of days on assisted ventilation was a slightly better predictor of the disease classification than days on > 60% oxygen. A statistical model correctly predicted the pathologic classification 83% of the time.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905882     DOI: 10.1002/(SICI)1099-0496(199610)22:4<215::AID-PPUL1>3.0.CO;2-L

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Factors affecting nasal intermittent positive pressure ventilation failure and impact on bronchopulmonary dysplasia in neonates.

Authors:  P Mehta; J Berger; E Bucholz; V Bhandari
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

3.  CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats.

Authors:  Shelley Drummond; Shalini Ramachandran; Eneida Torres; Jian Huang; Dorothy Hehre; Cleide Suguihara; Karen C Young
Journal:  Neonatology       Date:  2015-03-21       Impact factor: 4.035

4.  CT features of diffuse lung disease in infancy.

Authors:  Paolo Toma; Aurelio Secinaro; Oliviero Sacco; Davide Curione; Renato Cutrera; Nicola Ullmann; Claudio Granata
Journal:  Radiol Med       Date:  2018-03-22       Impact factor: 3.469

5.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

Authors:  P S McNamara; P Ritson; A Selby; C A Hart; R L Smyth
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

Review 7.  Imaging Bronchopulmonary Dysplasia-A Multimodality Update.

Authors:  Thomas Semple; Mohammed R Akhtar; Catherine M Owens
Journal:  Front Med (Lausanne)       Date:  2017-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.